Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Research Foundation 10.3389/fphar.2012.00174 Pharmacology Editorial Mechanisms of Ion Channels Voltage-Dependency: All about Molecular Sensors, Gates, Levers, Locks, and Grease Loussouarn Gildas 1 2 3 * Tarek Mounir 4 1Institut National de la Santé et de la Recherche Médicale, UMR1087 Nantes, France 2Centre National de la Recherche Scientifique, UMR 6291 Nantes, France 3L’institut du Thorax, L’UNAM Université, Université de Nantes Nantes, France 4Equipe de Chimie et Biochimie Théoriques, UMR Synthèse et Réactivité de Systèmes Moléculaires Complexes, Centre National de la Recherche Scientifique, Université de Lorraine Nancy, France

Edited by: Diana Conte Camerino, University of Bari Aldo Moro, Italy

*Correspondence: gildas.loussouarn@univ-nantes.fr

This article was submitted to Frontiers in Pharmacology of Ion Channels and Channelopathies, a specialty of Frontiers in Pharmacology.

 27 09 2012 2012 3 174 07 09 2012 11 09 2012 Copyright © 2012 Loussouarn and Tarek. 2012

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.

Given the wealth of electrophysiological, biochemical, optical, and structural data regarding ion channels voltage-dependency, we decided to put together in this special issue, up to date reviews describing the molecular details of these complex voltage-gated channels (and in one instance voltage-dependent phosphatases: Villalba-Galea, 2012). The articles focus mostly on the molecular mechanisms underlying channels voltage-dependency, such as the electromechanical coupling governing their activation, but also on molecular mechanisms governing their regulation by lipids. We anticipate that such knowledge will help one to better understand the pathophysiology of channelopathies (Choveau et al., 2012; Delemotte et al., 2012; Jurkat-Rott et al., 2012) and lead to new pharmacological approaches.

Molecular mechanisms underlying voltage-dependent activation and inactivation are complex, especially because channels are behaving in drastically different ways. Many reviews included in the present Research Topic issue describe models that rationalize these different behaviors:

– In some channels, e.g., HCN, KAT, activation is promoted by hyperpolarization while in others, e.g., Kv channels, it is promoted by depolarization, despite a similar global structure and behavior of their voltage sensors. The opposite behavior may come from different kinds of S4-S5/S6 interactions, that can be transient for hyperpolarization activated channel, permanent for depolarization activated channel (Blunck and Batulan, 2012), or bimodal, with the residues implicated in the S4-S5/S6 interaction being different in the open and closed states (Choveau et al., 2012). Along the same lines, the peculiar closed state inactivation observed in Kv4 channels may also come from a transient S4-S5/S6 interaction (Bähring et al., 2012).

– Forced uncoupling between the voltage sensor and the pore leads to opposite effects: this uncoupling favors channel closure of Shaker channels or, conversely, opening of the Kv-KcsA chimeric and KCNQ1 channels. This is most probably due to intrinsic properties of the pore, favoring a closed state in the former case and an open state in the latter (Blunck and Batulan, 2012; Vardanyan and Pongs, 2012).

– The nature of the gating motion of S6 falls into two categories as described in details by Labro and Snyders (2012). This may due to different constraints associated with the origin of the main stimulus, which comes from either the nearby voltage sensor domain or from a distal part of the C-terminus. C-terminal domains of Kv channels are indeed critical for the modulation of channel gating by signal transduction elements (Barros et al., 2012). These two categories may also be related with the intrinsic properties of the pore mentioned above (Vardanyan and Pongs, 2012).

– hERG is a very peculiar channel with slow activation gate and fast inactivation gate. Several molecular mechanisms (differences in voltage sensor dynamics, in the strength of S4-S5/S6 coupling, modulatory role of the N- and C-termini) may be at the origin of that peculiar behavior (Cheng and Claydon, 2012).

Finally, in addition to the pore forming subunits, membrane lipids (Choveau et al., 2012; Moreno et al., 2012; Rodríguez Menchaca et al., 2012), intracellular ions (Goodchild and Fedida, 2012), and β-subunits (Sun et al., 2012) that can associate with multiple stoichiometry (Wrobel et al., 2012) also modulate the channel voltage-dependency.

We hope that this series of reviews will bring researcher in the field (electrophysiologists, biochemists, modelers), a compendium of the knowledge gathered so far on the complex mechanisms of ion channel/enzyme voltage-dependency.

References Bähring R. Barghaan J. Westermeier R. Wollberg J. (2012). Voltage sensor inactivation in potassium channels. Front. Pharmacol. 3:100.10.3389/fphar.2012.00100 Barros F. Domínguez P. de la Peña P. (2012). Cytoplasmic domains and voltage-dependent potassium channel gating. Front. Pharmacol. 3:49.10.3389/fphar.2012.0004922470342 Blunck R. Batulan Z. (2012). Mechanism of electromechanical coupling in voltage-gated potassium channels. Front. Pharmacol. 3:166.10.3389/fphar.2012.0016622988442 Cheng Y. M. Claydon T. W. (2012). Voltage-dependent gating of hERG potassium channels. Front. Pharmacol. 3:83.10.3389/fphar.2012.0008322586397 Choveau F. S. Abderemane-Ali F. Coyan F. C. Es-Salah-Lamoureux Z. Baró I. Loussouarn G. (2012). Opposite effects of the S4–S5 linker and PIP2 on voltage-gated channel function: KCNQ1/KCNE1 and other channels. Front. Pharmacol. 3:125.10.3389/fphar.2012.0012522787448 Delemotte L. Klein M. L. Tarek M. (2012). Molecular dynamics simulations of voltage-gated cation channels: insights on voltage-sensor domain function and modulation. Front. Pharmacol. 3:97.10.3389/fphar.2012.0009722654756 Goodchild S. J. Fedida D. (2012). Contributions of intracellular ions to Kv channel voltage sensor dynamics. Front. Pharmacol. 3:114.10.3389/fphar.2012.0011422719727 Jurkat-Rott K. Groome J. Lehmann-Horn F. (2012). Pathophysiological role of omega pore current in channelopathies. Front. Pharmacol. 3:112.10.3389/fphar.2012.0011222701429 Labro A. J. Snyders D. J. (2012). Being flexible: the voltage-controllable activation gate of Kv channels. Front. Pharmacol. 3:168.10.3389/fphar.2012.0016822993508 Moreno C. Macias A. Prieto A. de la Cruz A. Valenzuela C. (2012). Polyunsaturated fatty acids modify the gating of Kv channels. Front. Pharmacol. 3:163.10.3389/fphar.2012.0016322973228 Rodríguez Menchaca A. A. Adney S. K. Zhou L. Logothetis D. E. (2012). Dual regulation of voltage-sensitive ion channels by PIP2. Front. Pharmacol. 3:170.10.3389/fphar.2012.00170 Sun X. Zaydman M. A. Cui J. (2012). Regulation of voltage-activated K+ channel gating by transmembrane β subunits. Front. Pharmacol. 3:63.10.3389/fphar.2012.0006322529812 Vardanyan V. Pongs O. (2012). Coupling of voltage-sensors to the channel pore: a comparative view. Front. Pharmacol. 3:145.10.3389/fphar.2012.0014522866036 Villalba-Galea C. A. (2012). Voltage-controlled enzymes: the new Janus Bifrons. Front. Pharmacol. 3:161.10.3389/fphar.2012.0016122993507 Wrobel E. Tapken D. Seebohm G. (2012). The KCNE tango – how KCNE1 interacts with Kv7.1. Front. Pharmacol. 3:142.10.3389/fphar.2012.0014222876232